RAD 2025: Renowned AD investigator Kircik provides the history behind the classwide black box warning, highlights JAK inhibitor efficacy, and toplines exciting AD research.
Leon Kircik, MD
Advertisement
Articles by Leon Kircik, MD
Advertisement
Latest Updated Articles
Q&A: JAK Inhibitor Safety in Context and the Rich Atopic Dermatitis Pipeline, with Leon Kircik, MDPublished: June 13th 2025 | Updated:
Advertisement
Advertisement
Trending on Patient Care Online
1
Centanafadine Granted FDA Priority Review for the Treatment of ADHD Across Pediatric and Adult Populations
2
Colorectal Cancer Becomes Leading Cause of Cancer Death in US Adults Younger Than 50 Years, Study Finds
3